Atherectomy Devices Market Size, Share and Technological Advancements 2018 to 2025
Global Atherectomy Devices Market is expected to witness rapid growth over the forecast period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein thrombosis (DVT) is expected to drive the market growth over the forecast period. Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness. This is expected to escalate the market growth of Atherectomy devices. Major factors such as rising life expectancy declining fertility rates play a major role in Atherectomy Devices Market growth in the foreseeable future.
Global Atherectomy Devices Market is expected to witness rapid growth over the forecast period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein thrombosis (DVT) is expected to drive the market growth over the forecast period. Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness. This is expected to escalate the market growth of Atherectomy devices. Major factors such as rising life expectancy declining fertility rates play a major role in Atherectomy Devices Market growth in the foreseeable future.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> <strong>Market</strong> <strong>Size</strong>, <strong>Share</strong> <strong>and</strong><br />
<strong>Technological</strong> <strong>Advancements</strong> <strong>2018</strong> <strong>to</strong> <strong>2025</strong><br />
<strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> <strong>Market</strong> Report provides in-depth analysis of industry by<br />
Production, <strong>Share</strong>, <strong>Size</strong>, Dem<strong>and</strong>, Proposition, Development, Opportunistic<br />
Growth, Economic Trends, Technologies Research, Segmentation, Key Futuristic<br />
Investment Feasibility, Major key players, SWOT Analysis <strong>and</strong> Forecast.<br />
Global <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> <strong>Market</strong> is expected <strong>to</strong> witness rapid growth over the forecast period.<br />
Increase in prevalence of Peripheral artery disease (PAD) <strong>and</strong> Deep vein thrombosis (DVT) is<br />
expected <strong>to</strong> drive the market growth over the forecast period. Increase in aging population in the<br />
US <strong>and</strong> in economically developed countries resulting in high requirement of medical devices for<br />
chronic illness. This is expected <strong>to</strong> escalate the market growth of <strong>Atherec<strong>to</strong>my</strong> devices. Major<br />
fac<strong>to</strong>rs such as rising life expectancy declining fertility rates play a major role in <strong>Atherec<strong>to</strong>my</strong><br />
<strong>Devices</strong> <strong>Market</strong> growth in the foreseeable future. Change in lifestyle trends <strong>and</strong> eating habits<br />
increase Consumption of cholesterol <strong>and</strong> fatty foods among individuals <strong>and</strong> lack of exercise which<br />
has been a major reason for coronary artery disease <strong>and</strong> high risk of heart attacks. Depending on<br />
the severity of the health issue atherec<strong>to</strong>my devices are used in the surgery by the doc<strong>to</strong>rs.<br />
Request Sample Copy of this <strong>Market</strong> Research @<br />
https://www.millioninsights.com/industry-reports/atherec<strong>to</strong>my-devices-market/request-sample
Diabetes, high blood pressure, obesity <strong>and</strong> smoking causes the blood arteries <strong>to</strong> marrow <strong>and</strong> limit<br />
the blood supply <strong>to</strong> the heart. It is estimated that 382 billion people throughout the world have<br />
diabetes. Environmental fac<strong>to</strong>rs such as foods, viruses, <strong>to</strong>xins <strong>and</strong> unbalanced work life play a role in<br />
development of diabetes. Growing number of patients with these vascular diseases are expected <strong>to</strong><br />
proliferate the dem<strong>and</strong> for atherec<strong>to</strong>my devices. Adopting advanced technology by using laser,<br />
ultraviolet radiation <strong>and</strong> recombinant issue technology <strong>and</strong> 3D image generation provides a better<br />
scope for the <strong>Atherec<strong>to</strong>my</strong> devices market. Added benefits such as minimal incisions, higher surgical<br />
res<strong>to</strong>ration rate, low pos<strong>to</strong>perative complications increase more patients opting for atherec<strong>to</strong>my<br />
devices.<br />
New technological advancements <strong>and</strong> the recent FDA approval of Two drug coated balloons are<br />
increasing atherec<strong>to</strong>my procedural volume <strong>and</strong> driving growth in the dem<strong>and</strong> for atherec<strong>to</strong>my<br />
devices Recalls of medical devices has been a major issue in pharmaceutical industry. Every device<br />
should maintain the st<strong>and</strong>ard quality <strong>and</strong> safety measures set by the Food <strong>and</strong> Drug Administration<br />
(FDA). All the manufacturing firms should ensure that the products are safe <strong>and</strong> do not endanger<br />
the end consumer. Athrec<strong>to</strong>my devices face a <strong>to</strong>ugh competition from Catheter (Tornus) which has<br />
been developed for chronic <strong>to</strong>tal occlusion recanalization. However, Catheter has a lower success<br />
rate of only 77% as compared <strong>to</strong> the traditional atherec<strong>to</strong>my devices with 95%. Tornus catheter is<br />
also associated with longer procedural duration time with 144 minutes versus the atherec<strong>to</strong>my<br />
devices 115 minutes.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/atherec<strong>to</strong>my-devices-market<br />
Lack of product differentiation forms a major challenge in the atherec<strong>to</strong>my <strong>Devices</strong> market. Most<br />
companies trying <strong>to</strong> enter the market find it hard <strong>to</strong> overcome the product differentiation because<br />
they require high investment <strong>and</strong> lack resources <strong>to</strong> create products that can compete with the<br />
existing ones. High cost <strong>and</strong> limited awareness in certain regions of the world act as a restraint for<br />
the market growth. <strong>Atherec<strong>to</strong>my</strong> technique is a popular substitute for stents <strong>and</strong> angioplasty<br />
treatments. In stents <strong>and</strong> angioplasty, the deposited plaque is pushed inside the blood vessel,<br />
however in atherec<strong>to</strong>my the plaque is removed by using surgical methods. The technique has
advantages over the other methods by providing increased wound healing rate The <strong>Atherec<strong>to</strong>my</strong><br />
<strong>Devices</strong> <strong>Market</strong> has been classified on the basis of its device functions such as rotational, orbital,<br />
excimer laser, excisional, directional <strong>and</strong> Jetstream atherec<strong>to</strong>my. The largest share of the market is<br />
occupied by orbital <strong>and</strong> directional atherec<strong>to</strong>my due <strong>to</strong> minimal invasive treatment, blood flow<br />
res<strong>to</strong>ration, reduction in procedure time <strong>and</strong> application in more complex cases. <strong>Market</strong> players are<br />
coming with better techniques <strong>and</strong> products <strong>to</strong> meet the requirement of the consumers.<br />
The <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> <strong>Market</strong> is segmented on the basis of geography such as North America,<br />
Europe, Asia pacific. North America is the leading player in the market followed by Europe.<br />
Peripheral artery disease affects nearly 10 million people <strong>and</strong> around 720,000 die every year due <strong>to</strong><br />
heart attack in US making it the potential market for the devices. Higher number of surgeries are<br />
being performed in US <strong>and</strong> Europe due <strong>to</strong> better awareness among people <strong>and</strong> also availability of<br />
resources making them the leading regions in the market. Asia pacific can be a potential market for<br />
atherec<strong>to</strong>my devices since countries such as India <strong>and</strong> china possess the largest number of cardiac<br />
patients with an annual incidence of 7 million strokes. Tobacco consumption is rapidly increasing in<br />
south Asian countries in conjunction with economic expansion increasing their risk of artery<br />
diseases.<br />
See More Reports of this Category by Million Insights @<br />
https://www.millioninsights.com/industry/medical-devices<br />
Reduction of abdominal obesity through lifestyle measures can improve all components of the<br />
metabolic syndrome <strong>and</strong> likely delay the development of both diabetes <strong>and</strong> atherosclerosis. Beyond<br />
lifestyle intervention, optimal management of risk fac<strong>to</strong>rs <strong>to</strong> evidence-based targets is essential.<br />
High awareness of health problems caused due <strong>to</strong> change in lifestyle <strong>and</strong> optimal management of<br />
risk fac<strong>to</strong>rs can improve the metabolic syndrome <strong>and</strong> likely reduce the development of both<br />
diabetes <strong>and</strong> atherosclerosis <strong>and</strong> hence reducing the dem<strong>and</strong> for the atherec<strong>to</strong>my devices. The<br />
major companies of the <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> <strong>Market</strong> include Bayer AG, Cardiovascular systems, St.<br />
Jude medica, Bos<strong>to</strong>n scientific corporation, Abbott labora<strong>to</strong>ries, C.R Bard Inc., Volcano Corporation.<br />
The competition in this <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> <strong>Market</strong> usually depends on the technology used in<br />
manufacturing of the devices <strong>and</strong> also the pricing strategies. Medtronic’s is leading competi<strong>to</strong>r in
peripheral atherec<strong>to</strong>my devices. Medtronic acquired Covedian in 2015 <strong>and</strong> is expected <strong>to</strong> remain in<br />
the leading position however it will face increasing competition from cardiovascular systems Inc.<br />
<strong>Market</strong> Segment:<br />
Geographically, this report is segmented in<strong>to</strong> several key Regions, with production, consumption,<br />
revenue (million USD), market share <strong>and</strong> growth rate of <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> in these regions,<br />
from 2013 <strong>to</strong> <strong>2025</strong> (forecast), covering<br />
• North America<br />
• Europe<br />
• China<br />
• Japan<br />
• Southeast Asia<br />
• India<br />
Global <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong> market competition by <strong>to</strong>p manufacturers, with production, price,<br />
revenue (value) <strong>and</strong> market share for each manufacturer; the <strong>to</strong>p players including<br />
• Bos<strong>to</strong>n Scientific Corp.<br />
• Cardiovascular Systems Inc.<br />
• Medtronic Plc<br />
• Spectranetics Corp.<br />
• Avinger Inc.<br />
• Royal Philips NV<br />
• Terumo Corp.<br />
On the basis of product, this report displays the production, revenue, price, market share <strong>and</strong><br />
growth rate of each type, primarily split in<strong>to</strong>
• Directional <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong><br />
• Orbital <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong><br />
• Rotational <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong><br />
• Laser <strong>Atherec<strong>to</strong>my</strong> <strong>Devices</strong><br />
On the basis of the end users/applications, this report focuses on the status <strong>and</strong> outlook for major<br />
applications/end users, consumption (sales), market share <strong>and</strong> growth rate for each application,<br />
including<br />
• Hospitals<br />
• ASCs<br />
• Clinics<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/atherec<strong>to</strong>my-devices-market
Get in <strong>to</strong>uch<br />
At Million Insights, we work with the aim <strong>to</strong> reach the highest levels of cus<strong>to</strong>mer satisfaction.<br />
Our representatives strive <strong>to</strong> underst<strong>and</strong> diverse client requirements <strong>and</strong> cater <strong>to</strong> the same with the<br />
most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Fel<strong>to</strong>n Office Plaza 6265 Highway 9<br />
Fel<strong>to</strong>n, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong><br />
Galleria, Model Colony, Shivaji Nagar,<br />
Pune, MH, 411016 India<br />
Phone: 91-20-65300184<br />
Email: sales@millioninsights.com<br />
Visit Our Blog:<br />
www.millioninsights.blogspot.com
Change language